N-Formyl leurosine
CAS: 54022-49-0
Ref. 3D-IF23552
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar |
Información del producto
- (3'a,4'a)-4'-Deoxy-3',4'-epoxy-22-oxovincaleukoblastineVincristine impurity G
- (2alpha,2'beta,3alpha,3'beta,4alpha,5beta,19beta)-22-oxo-O~3~',3'-cyclovincaleukoblastine
- 1H-Indolizino[8,1-cd]carbazole, vincaleukoblastine deriv.
- 22-Oxoleurosine
- 22-oxo-O~3~',3'-cyclovincaleukoblastine
- 2H-3,13-Methanooxireno[9,10]azacycloundecino[5,4-b]indole, vincaleukoblastine deriv.
- 4'-Desoxy-3'alpha,4'alpha-epoxyvincristin
- F-Leurosine
- Formyl-leurosine
- Formylleurosine
- Ver más sinónimos
- Leuroformine
- N-Demethyl-N-formylleurosine
- N-Formyl N-demethylleurosine
- N-Formylleurosine
- Nsc 269419
- Unii-I4U9Nzs9T5
- Vincaleukoblastine, 4'-deoxy-3',4'-epoxy-22-oxo-, (3'-alpha,4'-alpha)- (9CI)
- Vincaleukoblastine, 4′-deoxy-3′,4′-epoxy-22-oxo-, (3′α,4′α)-
- Vinformida
- Vinformida [INN-Spanish]
- Vinformide
- Vinformide [INN]
- Vinformidum
- Vinformidum [INN-Latin]
- f-Leu
N-Formyl leurosine is an inhibitor of fatty acid synthesis. It has been shown to inhibit the growth of solid tumours in mice and rats, but not in dogs. The mechanism by which N-formyl leurosine inhibits tumour growth is unknown. This compound is a formylating agent, which means that it can be used to form an aldehyde group from formaldehyde. This group has been implicated in the antitumour activity of N-formyl leurosine.
Propiedades químicas
Consulta técnica sobre: 3D-IF23552 N-Formyl leurosine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.